Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intergroup Trial for Children or Adolescents with Advanced Stage B-cell NHL or B-AL
2010-019224-31Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Oct 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of rituximab in mature B-cell lymphoma, B cell acute lymphoblastic leukemia (B-ALL) and follicular lymphoma (FL) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Minimum time to death or treatment failure. Started Oct 2011; status: completed.
02
Drugs
rituximab
03
Conditions
mature B-cell lymphomaB cell acute lymphoblastic leukemia (B-ALL)follicular lymphoma (FL)
Beyond the preview
Go deeper on 2010-019224-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019224-31.